PARIS (Reuters) - The European Medicines Agency has agreed to review an application by Sanofi and Regeneron for their cholesterol-lowering drug alirocumab, the pharmaceutical groups said in a statement.
via Reuters: Health News Read More Here..
No comments:
Post a Comment